immunotherapy

Allogeneic T cells may serve as universal, ready-to-use therapeutic agents for large scale clinical applications.

With childhood peanut allergies on the rise, scientists itch to find ways to prevent deadly reactions to this ubiquitous food.

The dream of oncology is precise targeting to destroy cancer cells while avoiding harm to healthy tissues. Identifying the unique proteins of a tumor might finally help reach that goal.

Using tiny chambers that release signals from a patient’s own tumor, scientists trigger immune cells to mount a personalized attack against the cancer.

Researchers identified immune cell imposters that are responsible for immune evasion in pancreatic cancer.

The complex interplay between bacteria and the tumor microenvironment informs cancer immunotherapy strategies.

By activating CAR T cells only in the presence of an antibody switch, Travis Young and his team hope to make this cancer treatment safer and more effective.

The live virus in the smallpox vaccine boosts the activity of cancer-killing immune cells for hard-to-treat tumors.

With videos of dramatic cancer cell deaths and unflagging T cell attacks, Alex Ritter studies how immune cells and tumors battle with microscopic precision.

The immune system comprises a treasure trove of cell types with the potential to destroy cancer cells.